These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Double blind trial of nialamide in intermittent claudication. Effects on blood cholesterol, fibrinolysis and 5-hydroxytryptamine. Tsapogas MJ; Flute PT Vasc Dis; 1964 Sep; 1(5):249-51. PubMed ID: 4867905 [No Abstract] [Full Text] [Related]
7. [A double blind crossover trial in pyridinolcarbamate treatment of atherosclerosis obliterans]. Yamashita S Nihon Naika Gakkai Zasshi; 1969 Apr; 58(4):283-92. PubMed ID: 4896659 [No Abstract] [Full Text] [Related]
8. The efficacy of oral beraprost sodium, a prostaglandin I2 analogue, for treating intermittent claudication in patients with arteriosclerosis obliterans. Matsumoto T; Iwasa K; Kyuragi R; Honma K; Guntani A; Ohmine T; Itoh H; Onohara T; Maehara Y Int Angiol; 2010 Apr; 29(2 Suppl):49-54. PubMed ID: 20357749 [TBL] [Abstract][Full Text] [Related]
9. The effect of naftidrofuryl (Praxilene) on intermittent claudication. Waters KJ; Craxford AD; Chamberlain J Br J Surg; 1980 May; 67(5):349-51. PubMed ID: 6992910 [TBL] [Abstract][Full Text] [Related]
10. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication]. Blume J; Kieser M; Hölscher U Vasa; 1996; 25(3):265-74. PubMed ID: 8967154 [TBL] [Abstract][Full Text] [Related]
11. A controlled trial of naftidrofuryl (Praxilene) in the treatment of intermittent claudication. Clyne CA; Galland RB; Fox MJ; Gustave R; Jantet GH; Jamieson CW Br J Surg; 1980 May; 67(5):347-8. PubMed ID: 6992909 [TBL] [Abstract][Full Text] [Related]
13. Electroneurography in intermittent claudication due to obliterative arteriosclerosis. Kumlin T; Seppäläinen AM; Railo J Angiology; 1974 Jun; 25(6):373-80. PubMed ID: 4367194 [No Abstract] [Full Text] [Related]
14. Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent claudication. Di Perri T; Guerrini M Angiology; 1983 Jan; 34(1):40-5. PubMed ID: 6824189 [TBL] [Abstract][Full Text] [Related]
15. Controlled trial of propranolol in hypertension. Zacharias FJ; Cowen KJ Br Med J; 1970 Feb; 1(5694):471-4. PubMed ID: 4907811 [TBL] [Abstract][Full Text] [Related]
16. Objective evaluation of cyclandelate in treatment of intermittent claudication associated with arteriosclerosis obliterans. Ross JV Vasc Dis; 1965 Sep; 2(5):300-4. PubMed ID: 5866204 [No Abstract] [Full Text] [Related]
17. Effect of cloricromene on intermittent claudication. A randomized, double-blind, placebo-controlled trial in patients treated with aspirin: effect on claudication distance and quality of life. CRAMPS Investigator Group. Cloricromene Randomized Arteriopathy Multicenter Prospective Study. Gresele P; Migliacci R; Di Sante G; Nenci GG; Vasc Med; 2000; 5(2):83-9. PubMed ID: 10943584 [TBL] [Abstract][Full Text] [Related]
18. Propranolol in hypertension: a dose-response study. Galloway DB; Glover SC; Hendry WG; Logie AW; Petrie JC; Smith MC; Lewis JA; Simpson WT Br Med J; 1976 Jul; 2(6028):140-2. PubMed ID: 776351 [TBL] [Abstract][Full Text] [Related]
19. The effectiveness of isoxsuprine in patients with intermittent claudication. Skotnicki SH; van Gaal G; Wijn PF Angiology; 1984 Nov; 35(11):685-93. PubMed ID: 6388424 [TBL] [Abstract][Full Text] [Related]